Intrauterine Growth Restriction and Later Cardiovascular Function
Overview
Pediatrics
Reproductive Medicine
Affiliations
Intrauterine growth restriction is one of the most common obstetric conditions, affecting 7-10% of fetuses. Affected fetuses are actually exposed in utero to an adverse environment during the highly critical time of development and may face life-long health consequences such as increased cardiovascular risk in adulthood. Already in utero, fetuses affected by growth restriction show remodeled hearts with signs of systolic and diastolic dysfunction. Cardiovascular remodeling persist into postnatal life, from the neonatal period to adolescence, suggesting a primary fetal cardiac programming that might explain the increased cardiovascular risk later in life. In this review we summarize the current evidence on fetal cardiovascular programming in fetuses affected by growth restriction, its consequences later and possible strategies from which they could benefit to reduce their cardiovascular risk.
Jiang Y, Liu P, Zeng M, Zhuang G, Qiu C, Wang L Sci Rep. 2025; 15(1):3497.
PMID: 39875511 PMC: 11775239. DOI: 10.1038/s41598-025-87955-z.
Fasoulopoulos A, Varras M, Varra F, Philippou A, Myoteri D, Varra V Mol Med Rep. 2025; 31(3.
PMID: 39791214 PMC: 11751665. DOI: 10.3892/mmr.2025.13434.
Zhang W, Zhang B, Wu T, Li Y, Qi X, Tian Y Quant Imaging Med Surg. 2024; 14(12):8155-8166.
PMID: 39698698 PMC: 11651951. DOI: 10.21037/qims-24-794.
Ziegler A, Lawton S, Fekete E, Brozoski D, Wagner V, Grobe C Am J Physiol Regul Integr Comp Physiol. 2024; 328(1):R109-R120.
PMID: 39548798 PMC: 11905802. DOI: 10.1152/ajpregu.00250.2024.
Van S, Cui J, Wang Y, Jiang H, Sha F, Li Y Bioengineering (Basel). 2024; 11(7).
PMID: 39061738 PMC: 11274223. DOI: 10.3390/bioengineering11070657.